Arthritis Clinical Trials in Maryland

39 recruiting studies across 1 city

Browse by City

All Trials in Maryland

Phase

Trial	Phase	Sponsor	Dist.
A Phase 1/2a to Evaluate the Safety and Efficacy of Adipose Tissue Allograft (BRC-OA) in Patients With Osteoarthritis of the Knee	Phase 1/2	Britecyte	<1 mi
Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancer	Phase 1	National Cancer Institute (NCI)	<1 mi
The Myelin Disorders Biorepository Project	—	Children's Hospital of Philadelphia	<1 mi
RA-PRO PRAGMATIC TRIAL	Phase 3	University of Alabama at Birmingham	<1 mi
Innovations in Genicular Outcomes Registry	—	Pacira Pharmaceuticals, Inc	<1 mi
Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis Naive to Biologic Disease-Modifying Antirheumatic Drug	Phase 3	MoonLake Immunotherapeutics AG	<1 mi
A Study of Guselkumab Administered Subcutaneously in Bio-naive Participants With Active Psoriatic Arthritis Axial Disease	Phase 4	Janssen Research & Development, LLC	<1 mi
Sleep TO Prevent Post-surgical Pain	N/A	Johns Hopkins University	<1 mi
A Study to Investigate Efficacy and Safety of AZD1163 in Participants With Rheumatoid Arthritis	Phase 2	AstraZeneca	<1 mi
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic Medicines	Phase 3	Takeda	<1 mi
A Study to Evaluate the Efficacy and Safety of Deucravacitinib in Adults With Active Sjögren's Syndrome	Phase 3	Bristol-Myers Squibb	<1 mi
Platelet Rich Plasma Versus Corticosteroids in Hip Osteoarthritis Pain	Phase 4	LifeBridge Health	<1 mi
Prospective Functional, Gait, and Outcome Comparison Study of Medial Pivot Versus Single Radius Design for Total Knee Arthroplasty	N/A	LifeBridge Health	<1 mi
Evaluate the Safety and Effectiveness of the Polymotion Hip Resurfacing (PHR) System Compared to Total Hip Arthroplasty	N/A	JointMedica Inc.	<1 mi
Chronic Pain in Rheumatoid Arthritis	—	Northwestern University	<1 mi
The Pericapsular Nerve Block in Total Hip Arthroplasty	Phase 4	LifeBridge Health	<1 mi
Post Approval Study2: Hintermann Series H3 Total Ankle Replacement System	N/A	DT MedTech, LLC	<1 mi
Primary Subtalar Arthrodesis for Calcaneal Fractures	N/A	Wake Forest University Health Sciences	<1 mi
Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis and Anti-TNFα Inadequate Response	Phase 3	MoonLake Immunotherapeutics AG	<1 mi
Safety and Effectiveness of the HIT Reverse HRS	N/A	Hip Innovation Technology	<1 mi
A Study of CC-97540, CD-19-Targeted Nex-T CAR T Cells, in Participants With Severe, Refractory Autoimmune Diseases (Breakfree-1)	Phase 1	Juno Therapeutics, Inc., a Bristol-Myers Squibb Company	<1 mi
Safety and Efficacy of ABP-745 in Participants With an Acute Gout Flare	Phase 2	Atom Therapeutics Co., Ltd	9 mi
A Study of Dotinurad Versus Allopurinol in Participants With Gout	Phase 3	Crystalys Therapeutics	32 mi
Hemophagocytic Lymphohistiocytosis (HLH) Evaluation and Research of Clinical, ImmUnoLogic and TranscriptomE Study	—	National Institute of Allergy and Infectious Diseases (NIAID)	34 mi
Natural History, Genetics, and Pathophysiology of Systemic Juvenile Idiopathic Arthritis, Adult-Onset Still's Disease, and Related Conditions	—	National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)	34 mi
Study of Alkaptonuria	—	National Human Genome Research Institute (NHGRI)	34 mi
Studies of the Natural History of Rheumatic Diseases	—	National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)	34 mi
Natural History and Development of Spondyloarthritis	—	National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)	34 mi
Characterization of Diseases With Salivary Gland Involvement	—	National Institute of Dental and Craniofacial Research (NIDCR)	34 mi
The Pathogenesis and Natural History of Sjogren's Disease	—	National Institute of Dental and Craniofacial Research (NIDCR)	34 mi
Safety of Tofacitinib, an Oral Janus Kinase Inhibitor, in Primary Sjogren Disease	Phase 2	National Institute of Dental and Craniofacial Research (NIDCR)	34 mi
Studies of the Natural History, Pathogenesis, and Outcome of Idiopathic Systemic Vasculitis	—	National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)	34 mi
Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry	—	Duke University	36 mi
Study of Oral Upadacitinib and Subcutaneous/Intravenous Tocilizumab to Evaluate Change in Disease Activity, Adverse Events and How Drug Moves Through the Body of Pediatric and Adolescent Participants With Active Systemic Juvenile Idiopathic Arthritis.	Phase 3	AbbVie	36 mi
A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or Adalimumab	Phase 3	AbbVie	36 mi
Development of a Therapeutic Endpoint in Pediatric Rheumatologic Conditions	—	Children's National Research Institute	36 mi
NSAIDs vs. Coxibs in the Presence of Aspirin	Phase 4	Inova Health Care Services	41 mi
Systemic Oral Glucocorticoids for the Treatment of Acute Osteoarthritis Pain in the Emergency Department	Phase 4	WellSpan Health	47 mi
A Long-term Extension Study of Ustekinumab in Pediatric Participants	Phase 3	Janssen Research & Development, LLC	48 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.